Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Emmanouil N. Rizos, Athanasia Papadopoulou, Efstathios Laskos, Panagiota G. Michalopoulou, Anastasia Kastania, Dimitrios Vasilopoulos, Konstantinos Katsafouros & Lefteris Lykouras. (2010) Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics. The World Journal of Biological Psychiatry 11:2-2, pages 251-255.
Read now
Read now
Yusra Ahmad, Manjeet S. Bhatia, Pramod K. Mediratta, Krishna K. Sharma, Harsh Negi, Kunzang Chosdol & Subrata Sinha. (2009) Association between the ionotropic glutamate receptor kainate3 (GRIK3) Ser310Ala polymorphism and schizophrenia in the Indian population. The World Journal of Biological Psychiatry 10:4, pages 330-333.
Read now
Read now
Gabriela Novak, Julien Boukhadra, Sajid A. Shaikh, James L. Kennedy & Bernard Le Foll. (2009) Association of a polymorphism in the NRXN3 gene with the degree of smoking in schizophrenia: A preliminary study. The World Journal of Biological Psychiatry 10:4-3, pages 929-935.
Read now
Read now
Articles from other publishers (18)
Remzi Oguz Baris, Nilfer Sahin, Ayşegül Demirtas Bilgic, Cilem Ozdemir & Tuba Gokdogan Edgunlu. (2023) Molecular and in silico analyses of SYN III gene variants in autism spectrum disorder. Irish Journal of Medical Science (1971 -) 192:6, pages 2887-2895.
Crossref
Crossref
Benazir Rowe, Xiangning Chen, Zuoheng Wang, Jingchun Chen & Amei Amei. (2019) Biological and practical implications of genome-wide association study of schizophrenia using Bayesian variable selection. npj Schizophrenia 5:1.
Crossref
Crossref
Teodor T. Postolache, Laura Bosque‐Plata, Serge Jabbour, Michael Vergare, Rongling Wu & Claudia Gragnoli. (2019) Co‐shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 180:3, pages 186-203.
Crossref
Crossref
Zhifan Zhou, Zhengmao Hu, Lu Zhang, Zhaoting Hu, Haihong Liu, Zhening Liu, Juan Du, Jingping Zhao, Lin Zhou, Kun Xia, Bengsha Tang & Lu Shen. (2016) Identification of RELN variation p.Thr3192Ser in a Chinese family with schizophrenia. Scientific Reports 6:1.
Crossref
Crossref
Laura E. Perlini, Joanna Szczurkowska, Bryan A. Ballif, Alessandra Piccini, Silvio Sacchetti, Silvia Giovedì, Fabio Benfenati & Laura Cancedda. (2015) Synapsin III Acts Downstream of Semaphorin 3A/CDK5 Signaling to Regulate Radial Migration and Orientation of Pyramidal Neurons In Vivo. Cell Reports 11:2, pages 234-248.
Crossref
Crossref
Helios Pareja‐Galeano, Sara Mayero & Fabian Sanchis‐Gomar. 2015. Diet and Exercise in Cognitive Function and Neurological Diseases. Diet and Exercise in Cognitive Function and Neurological Diseases
323
337
.
Yingying Wang, Zichun Zeng & Yunpeng Cai. 2015. Health Information Science. Health Information Science
174
184
.
Timothy D. Folsom & S. Hossein Fatemi. (2013) The involvement of Reelin in neurodevelopmental disorders. Neuropharmacology 68, pages 122-135.
Crossref
Crossref
A.M. Persico. 2013. Neural Circuit Development and Function in the Brain. Neural Circuit Development and Function in the Brain
651
694
.
Diego Tovar, Eduardo Cornejo, Petros Xanthopoulos, Mario R. Guarracino & Panos M. Pardalos. 2012. Psychiatric Disorders. Psychiatric Disorders
593
603
.
Barbara Porton, William C. Wetsel & Hung-Teh Kao. (2011) Synapsin III: Role in neuronal plasticity and disease. Seminars in Cell & Developmental Biology 22:4, pages 416-424.
Crossref
Crossref
Erik G. Jönsson, Peter Saetre, Maria Vares, Pontus Strålin, Sten Levander & Eva Lindström. (2011) Use of antipsychotics — An analysis of lifetime treatment in 66 patients with psychoses. Psychiatry Research 187:1-2, pages 80-88.
Crossref
Crossref
Ripu D. Jindal, Anil K. Pillai, Sahebrao P. Mahadik, Kevin Eklund, Debra M. Montrose & Matcheri S. Keshavan. (2010) Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia. Schizophrenia Research 119:1-3, pages 47-51.
Crossref
Crossref
For-Wey Lung, Bih-Ching Shu, Wei-Tsung Kao, C Nathan Chen, Yu-Chi Ku & Dong-Sheng Tzeng. (2009) Association of DRD4 uVNTR and TP53 codon 72 polymorphisms with schizophrenia: a case-control study. BMC Medical Genetics 10:1.
Crossref
Crossref
Andrea Schmitt, Eleni Parlapani, Oliver Gruber, Thomas Wobrock & Peter Falkai. (2008) Impact of neuregulin-1 on the pathophysiology of schizophrenia in human post-mortem studies. European Archives of Psychiatry and Clinical Neuroscience 258:S5, pages 35-39.
Crossref
Crossref
Anna K. Kähler, Srdjan Djurovic, Bettina Kulle, Erik G. Jönsson, Ingrid Agartz, Håkan Hall, Stein Opjordsmoen, Klaus D. Jakobsen, Thomas Hansen, Ingrid Melle, Thomas Werge, Vidar M. Steen & Ole A. Andreassen. (2008)
Association analysis of schizophrenia on 18 genes involved in neuronal migration:
MDGA1
as a new susceptibility gene
. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 147B:7, pages 1089-1100.
Crossref
Crossref
Erminio Costa, Ying Chen, Erbo Dong, Dennis R. Grayson, Alessandro Guidotti & Marin Veldic. 2008. Reelin Glycoprotein. Reelin Glycoprotein
341
363
.
Undine E. Lang, Imke Puls, Daniel J. Müller, Nathalie Strutz-Seebohm & Jürgen Gallinat. (2007) Molecular Mechanisms of Schizophrenia. Cellular Physiology and Biochemistry 20:6, pages 687-702.
Crossref
Crossref